Treatment of Infantile Hemangiomas Using a Novel 650-microsecond Pulsed Nd:YAG 1064nm Laser
David Goldberg, MD, Gulia Kasimova, MD, Skin Laser & Surgery Specialists, Hillsborough, NJ; Laser Medicine and Cosmetic Clinic, Kirov, Russia
Background
This study was conducted to evaluate the safety and clinical efficacy of a 650-microsecond Short Pulsed Nd:YAG 1064nm Laser for treatment of Infantile Hemangiomas.
Study
A total of 250 subjects with infantile hemangiomas were treated over a study period of 5 years, mostly aged 1–4 months, 60% female, skin types I–II. An Nd:YAG 1064nm laser was used with a 2–3 mm spot size, 650-microsecond pulse duration and fluence of 42–64 J/cm2. Consecutive treatments were performed in 1–4 month intervals. Photos were taken before, immediately after, 30 and 180 days after each treatment session.
Results
100% of the subjects exhibited substantial improvement after just on treatment. Treatment time was fast and did not exceed 3–5 minutes for treatment of areas up to 3 cm2. Patients tolerated the treatment very well with the youngest subjects appearing to tolerate it best. Parents were highly satisfied with the treatment results. No complications were observed.
Conclusion
A 650-Microsecond Pulsed Nd:YAG 1064nm Laser delivers a high rate of clearance of infantile hemangiomas with no adverse skin effects.
As presented at the 2016 Annual Meeting of the American Society for Laser Medicine & Surgery ASLMS
Comparative Study Of The Effectiveness Of Papulopustular Rosacea Subtype By Pulsed Dye Laser (595nm) And a Neodymium Laser (1064nm) With a Short 650 Microsecond Pulse Width
Improvement of Rosacea-associated Facial Erythema and Telangiectasias in Skin of Color with a 650-microsecond 1064nm Nd:YAG Laser
